Literature DB >> 20633755

Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy.

Avinash Waghmare1, Channaveerachari Naveen Kumar, Jagadisha Thirthalli.   

Abstract

Suxamethonium causes prolonged apnea in patients in whom pseudocholinesterase enzyme gets deactivated by organophosphorus (OP) poisons. Here, we present a similar incident in a severely depressed patient who received electroconvulsive therapy (ECT). Prolonged apnea in our case ensued because the information about suicidal attempt by OP compound was concealed from the treating team. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20633755     DOI： 10.1016/j.genhosppsych.2009.11.001

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN： 0163-8343            Impact factor:   3.238


  4 in total

1.  Position statement and guidelines on unmodified electroconvulsive therapy.

Authors:  Chittaranjan Andrade; N Shah; P Tharyan; M S Reddy; M Thirunavukarasu; R A Kallivayalil; R Nagpal; N K Bohra; A Sharma; E Mohandas
Journal:  Indian J Psychiatry       Date:  2012-04       Impact factor: 1.759

2.  Prolonged apnea during electroconvulsive therapy in monozygotic twins: case reports.

Authors:  Maxim Zavorotnyy; Peter Zwanzger
Journal:  Ann Gen Psychiatry       Date:  2011-11-03       Impact factor: 3.455

3.  A Case Report of Prolonged Apnea during ECT in a Patient with Suicidal Attempt by Organophosphorus Poison.

Authors:  Sussan Moudi; Ebrahim Alijanpour; Ali-Asghar Manouchehri; Hasan Jafarian
Journal:  Iran J Psychiatry Behav Sci       Date:  2012

4.  Prolonged apnea after ECT in organophosphorus poisoning - the need to redefine norms.

Authors:  Shibu Sasidharan; Harpreet Singh Dhillon
Journal:  BMC Psychiatry       Date:  2021-03-10       Impact factor: 3.630
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.